Exro Technologies Discontinues US Business
It is anticipated that the Toronto Stock Exchange (the "TSX") will place the Company under delisting review and there can be no assurance as to the outcome of such review or the continued qualification for listing on the TSX.
Neither the Toronto Stock Exchange nor the Canadian Investment Regulatory Organization accepts responsibility for the adequacy or accuracy of this press release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/exro-technologies-discontinues-us-business-302559586.html
SOURCE Exro Technologies Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dr. Gary Lawton Yale-Trained Plastic Surgeon: New Non-Opioid Pain Medication for Recovery Protocols
- Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
- Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share